Concurrent Investment Advisors LLC Has $1.03 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Concurrent Investment Advisors LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,277 shares of the company’s stock after selling 1,306 shares during the period. Concurrent Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $1,025,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Swedbank AB grew its stake in Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after purchasing an additional 40,324 shares in the last quarter. Private Advisor Group LLC grew its stake in Colgate-Palmolive by 5.4% in the third quarter. Private Advisor Group LLC now owns 68,952 shares of the company’s stock valued at $7,158,000 after purchasing an additional 3,543 shares in the last quarter. International Assets Investment Management LLC grew its stake in Colgate-Palmolive by 13,776.8% in the third quarter. International Assets Investment Management LLC now owns 435,871 shares of the company’s stock valued at $45,248,000 after purchasing an additional 432,730 shares in the last quarter. Hennion & Walsh Asset Management Inc. grew its stake in Colgate-Palmolive by 4.2% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 20,975 shares of the company’s stock valued at $2,177,000 after purchasing an additional 851 shares in the last quarter. Finally, Ballentine Partners LLC boosted its stake in shares of Colgate-Palmolive by 100.9% during the 3rd quarter. Ballentine Partners LLC now owns 20,547 shares of the company’s stock worth $2,133,000 after acquiring an additional 10,318 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.9 %

Colgate-Palmolive stock opened at $89.56 on Friday. The business has a 50 day moving average price of $88.94 and a two-hundred day moving average price of $95.86. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market cap of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $84.45 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business posted $0.87 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. Colgate-Palmolive’s payout ratio is presently 56.82%.

Analysts Set New Price Targets

Several analysts have recently issued reports on CL shares. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Finally, JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.